Efficacy and tolerability of 12-weeks oral treatment with V0355CP3A versus Ferrograd, in iron deficiency anaemia. Multicenter, randomised, open-label trial
Efficacy and tolerability of 12-weeks oral treatment with V0355CP3A versus Ferrograd, in iron deficiency anaemia. Multicenter, randomised, open-label trial
Efficacy and tolerability of 12-weeks oral treatment with V0355CP3A versus Ferrograd, in iron deficiency anaemia. Multicenter, randomised, open-label trial
Status
Status :
Completed
Type of study
Phase III
Min. Age
18
Years old
Max. Age
50
Years old
Gender
Female
Therapeutic area :
Blood Disorders
Disease :
Anaemia
Study medication :
V0335
Phase :
Phase III
Start Date :
29 February 2008
End date :
31 March 2009
Study ID :
V00355 CP301 3A
EudraCT/CTIS number :
2007-004139-49
Send by email